Matthew Glover

Matthew Glover is currently the Associate Director of Proteomics at AstraZeneca, where they manage a team of scientists focused on advancing preclinical pipeline projects for Early Oncology R&D. They have seven years of experience in biopharma R&D, specializing in mass spectrometry and -omics technologies for drug discovery and target validation. Glover's previous roles include positions as Senior Scientist and Team Leader at AstraZeneca, as well as a Postdoctoral Research Fellow at the University of Wisconsin-Madison, where they contributed to significant advancements in vascular disease research. Glover holds a Ph.D. in Chemistry from Indiana University Bloomington and a B.A. in Chemistry from Franklin College.